Resources

Launching a clinical trial for a drug intended to treat severe asthma during a respiratory pandemic — particularly one that seems to hit people with some types of asthma particularly hard — could be a risky move. Read more. The post Startup Spotlight: Bullish on its...

Fancy a Black Friday R&D deal? Astellas has you covered badams Wed, 11/25/2020 - 08:32

Cancer-killing virus escapes immune destruction and fights metastatic lung tumors in mice arlene.weintraub Wed, 11/25/2020 - 07:43

BioNTech, Fosun start COVID-19 vaccine trial to support Chinese approval ntaylor Wed, 11/25/2020 - 06:47

Urovant's vibegron flunks irritable bowel syndrome phase 2 ntaylor Wed, 11/25/2020 - 06:01

Galapagos sells off Fidelta as CRO activities 'no longer fit with its strategy' badams Wed, 11/25/2020 - 04:01

Biotech punches way above its weight-class, and that’s never been more apparent than in this pandemic and the race for a COVID vaccine. Read more. The post Biotech: The Featherweight Champion Of The Markets appeared first on Atlas Venture.

The Association of Medical Device Reprocessors (AMDR) appreciates the Commission’s efforts to promote a cleaner and more competitive Europe. We welcome the opportunity to provide feedback to the Inception Impact Assessment on the Sustainable Products Initiative. –...

Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced today that Rajesh (Raj) Devraj, PhD, is joining the firm as a venture partner. Devraj will be working with the Atlas team to identify and execute upon...

LONDON (Reuters) – European Union governments approved a 1 trillion euro ($1.2 trillion) green “roadmap” for the bloc’s lending arm on Wednesday that will see it stop financing fossil fuel projects and airport expansions, though climate groups said it did not go far...

Why was the United States left scrambling for critical medical equipment as the coronavirus swept the country? With the Associated Press and Global Reporting Centre, FRONTLINE investigates the fragmented global medical supply chain and its deadly consequences. View...

(Washington, DC – 9 November 2020) A September 9, 2020 article published in Surgical Endoscopy, “Assessing Organic Material on Single-Use Vessel Sealing Devices: A Comparative Study of Reprocessed and New LigaSure Devices,” appears to contain significant conflict of...

Regardless of their sophistication and complexity, many high-tech medical instruments are designated for single use because the original manufacturer did not develop a procedure allowing for the safe reuse of the device. However, the ‘easy’ option of simply throwing...

Cyrus Mozayeni got excited when he began to explore the academic work of Ehud Isacoff and John G. Flannery at UC Berkeley. Read more. The post Novartis buys a new gene therapy for vision loss, and this is one preclinical venture that didn’t come cheap appeared first...

In a recent blog post, I walked through my tips for reading your adversaries’ body language while maintaining your own poker face throughout negotiations. In this second post, I’ll share practical tactics for gaining leverage and using it wisely. Women of biotech,...

When Gary Glick, Ph.D. left the CEO post at IFM Therapeutics, he didn’t know what was next. But he soon found himself on a plane with Loxo Oncology co-founder Keith Flaherty, and they got to talking about how they could “expand the boundaries of targeted oncology.”...

It’s back-to-school season, and that puts me in the frame of mind to share some of the most important lessons I’ve learned in a long career focusing on one of the most daunting pillars of the biopharma BD world: the negotiation. By Deanna Petersen, Chief Business...

The drug industry has funneled billions of dollars into cell therapies over the last several years. But there may be something new on the horizon, and a new Cambridge startup is angling to be at the forefront. Read more. The post Longwood, Atlas Venture inject $52M...

I have many fond memories of St Patrick’s Day—most of them involve marching in the parade with a plastic bag and a few extra layers under my girl scout uniform. When you grow up in Ireland, cold rain is not grounds to cancel anything. By Aoife Brennan, CEO of Synlogic...

SPACs are all the rage today. With the IPO market booming and public investors seeking better returns, blank check companies called “Special Purpose Acquisition Companies” (SPACs) have been fueling up their tanks and chasing down their merger targets. New ones are...

Exogenesis has announced that its Exogenesis Surgical Mask (ESM) has achieved primary endpoints of trapping and deactivating Covid-19 viral particles in simulated real-world exposures during a series of challenge tests. The ESM is intended to offer protective nose and...

9 October The US economy showed some signs of recovery in the third quarter of 2020 but unemployment claims continue to remain above pre-pandemic levels. Layoffs are expected to rise over the next few months hampering recovery. Ben Casselman, economics/business/data...

8 October Global: The global coronavirus death toll is 1,057,102 according to researchers at Johns Hopkins University. Covid-19 infections exceed 36.2 million world wide. US: Covid-19 infections exceed 7.5 million, meanwhile, the US coronavirus death toll is 211,917...

Orthofix Medical has launched a new O-GENESIS Graft Delivery System together with AlloQuent Structural Allograft Q-Pack, a ready-to-use form of cervical and lumbar spacers for allograft procedures. The O-GENESIS Graft Delivery System is designed to provide allograft,...

8 October Francesco Saraceno, Italian economist, shared an article on European Central Bank (ECB) President Christine Lagarde’s plans to retain monetary support until the crisis created by the Covid-19 pandemic is over. She noted that the policies adopted in the euro...